company background image
QTNT

Quotient NasdaqGM:QTNT Stock Report

Last Price

US$0.16

Market Cap

US$21.8m

7D

-4.5%

1Y

-94.7%

Updated

05 Oct, 2022

Data

Company Financials +
QTNT fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health0/6
Dividends0/6

QTNT Stock Overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally.

Quotient Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Quotient
Historical stock prices
Current Share PriceUS$0.16
52 Week HighUS$3.19
52 Week LowUS$0.14
Beta2.75
1 Month Change-8.09%
3 Month Change-45.94%
1 Year Change-94.74%
3 Year Change-97.81%
5 Year Change-96.88%
Change since IPO-97.57%

Recent News & Updates

Aug 24

Quotient expands MosaiQ Innovator's Circle

Quotient Limited (NASDAQ:QTNT) has announced the National Screening Laboratory of Sanquin Blood Supply Foundation, Department Research & Labservices has joined MosaiQ Innovator’s Circle. Sanquin Blood Supply is responsible for safe and efficient blood supply in the Netherlands. Members of the Innovator’s Circle partner with Quotient to create innovation and evidence generation to improve patient care and laboratory efficiencies. “We believe in the power of fostering connections, and we’re honored to have Sanquin join our community of experts to achieve a common goal—improve clinical practices and transform patient care on a global scale,” said Manuel O. Méndez, CEO of Quotient.

Shareholder Returns

QTNTUS Medical EquipmentUS Market
7D-4.5%4.2%1.9%
1Y-94.7%-25.9%-18.8%

Return vs Industry: QTNT underperformed the US Medical Equipment industry which returned -25.7% over the past year.

Return vs Market: QTNT underperformed the US Market which returned -18.2% over the past year.

Price Volatility

Is QTNT's price volatile compared to industry and market?
QTNT volatility
QTNT Average Weekly Movement15.1%
Medical Equipment Industry Average Movement8.6%
Market Average Movement7.0%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: QTNT is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: QTNT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2007437Manuel Mendezhttps://www.quotientbd.com

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping.

Quotient Limited Fundamentals Summary

How do Quotient's earnings and revenue compare to its market cap?
QTNT fundamental statistics
Market CapUS$21.77m
Earnings (TTM)-US$136.71m
Revenue (TTM)US$38.24m

0.6x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
QTNT income statement (TTM)
RevenueUS$38.24m
Cost of RevenueUS$24.91m
Gross ProfitUS$13.33m
Other ExpensesUS$150.03m
Earnings-US$136.71m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.01
Gross Margin34.85%
Net Profit Margin-357.50%
Debt/Equity Ratio-173.3%

How did QTNT perform over the long term?

See historical performance and comparison